CohBar is focused on a previously untapped field of biology based on a fundamental breakthrough demonstrating the critical role of mitochondrially-derived peptides (MDPs) in age-related diseases. Mitochondrial dysfunction is now implicated in many common age-related diseases including type 2 diabetes mellitus (T2DM), cardiovascular disease, Parkinson´s disease, dementia, and cancer as well as in the aging process itself. CohBar is developing a proprietary series of novel MDPs that will be the next generation of innovative new drugs to treat age related diseases.